Cracking the Code of Cholesterol: Mastering Non-Statin Therapies in Cardiovascular Medicine - Live Webinar on February 3, 2025 8PM ET
Learn the pathophysiology of atherosclerotic vascular disease, explore non-statin lipid-lowering therapies, and gain insights into managing hyperlipidemia in statin-intolerant patients to reduce cardiovascular risk.
About this webinar
Cardiovascular disease (CVD) remains the leading cause of death in the U.S. despite public health initiatives. Hyperlipidemia is a major risk factor for developing CVD, and strong clinical evidence supports the use of statin therapy to reduce the risk of cardiovascular events. However, statin therapy is not always feasible for all patients due to contraindications and adverse events. Statin intolerance occurs in 5-20% of patients, particularly older adults. Thus, healthcare professionals need to learn about non-statin lipid-lowering agents to provide alternative therapeutic pathways for patients with statin intolerance.
This course will delve into the pathophysiology of atherosclerotic vascular diseases and identify biological targets for drug intervention. It will also cover various non-statin treatment options, their clinical applications, and potential adverse effects, providing healthcare professionals with comprehensive insights into managing hyperlipidemia and reducing cardiovascular risk.
At the conclusion of this course, participants will be able to:
Discuss the epidemiology and pathophysiology of cardiovascular diseases.
Explain the role of statins in managing hypercholesterolemia.
List and describe the adverse effects and contraindications of statin therapy.
Outline and discuss the use of non-statin lipid-lowering therapy in cardiovascular diseases.
Instructors
Dr. Fandy is both a pharmacist and a pharmaceutical scientist. He practiced pharmacy in Maryland, Vermont, and West Virginia and is currently a Board Certified Geriatric Pharmacist (BCGP). He obtained his Master’s and Ph.D. degrees in pharmaceutical sciences from the University of Southern California and the University of Maryland, respectively. He started his academic career as an Assistant Professor at Albany College of Pharmacy in 2010 and then joined the school of pharmacy at the University of Charleston in 2016, where he serves as the Professor & Chair of the Department of Pharmaceutical & Administrative Sciences. Dr. Fandy is a fellow of the American College of Clinical Pharmacology, and his research focuses on oncology, pharmacology, and experimental therapeutics.